Skip to content
Governance Register

← US public companies

Femasys INC

SEC CIK 1339005 · FEMY · last insider filing 2026-04-01

Directors (from insider filings)

NameCapacity as filedFilings
Lee-Sepsick Kathy Director · Chief Executive Officer filed 2021 - 2026
Larsen Charles Director filed 2021 - 2026
Eichenbaum Kenneth D. Director filed 2026 - 2026
Silverman Joshua Director filed 2023 - 2026
Uzialko Edward R Director filed 2021 - 2025
Milnes Alistair Director filed 2023 - 2025
Perrow Wendy Director filed 2022 - 2023
Morrissey Anne Director filed 2021 - 2023
Kendall Keith J Director filed 2023 - 2023
Dyett John Director filed 2021 - 2022
Adams John Q JR Director filed 2021 - 2022
Witte William Benson Director filed 2021 - 2021
Thompson Gary Director · VP, Finance & Administration filed 2021 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Canning John Charles Chief Operating Officer filed 2026 - 2026
Elefant Dov Chief Financial Officer filed 2022 - 2026
Sipos Jeremy Alexander Chief Technology Officer filed 2026 - 2026
Nicholas Kelley Stinson Chief Commercial Officer filed 2025 - 2025
Currie Daniel Scott Senior VP, Operations filed 2021 - 2025
Thomas Christine E SVP, Regulatory & Clinical filed 2022 - 2025
Spector Richard D. Chief Commercial Officer filed 2024 - 2024
Evantash Edward Chief Medical Officer filed 2021 - 2021
Kelley Hoskin Violet Alexandria VP, Clinical & Medical Affairs filed 2021 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.